case study Case study: Synthetic data for quality control in genomic pathology CSIRO’s Transformational Bioinformatics group creates a quality control pipeline for genomic pathology
Bioinformatics Student Exchange Program (BSEP) 2024 The Bioinformatics Student Exchange Program (BSEP) is open for 2024, offering bioinformatics internships in Australia. BSEP is aimed at overseas students, giving them the opportunity to contribute to world-class science and gain experience
Scientific publication Towards risk governance of clinical genomics in Australia Professionals within the clinical genomics system recognise the significant benefits of genomics in healthcare, but they hold divergent perspectives on the ethical, technical, and social risks involved.
Commentary Genomic Data Privacy in the Era of Decentralised Systems Genomic data privacy concerns addressed by DLT. Benefits: data ownership control, improved security, encrypted data sharing. Challenges: user adoption, user-friendliness
Conference Reflections on Neuro-and-Symbolic AI for Bioinformatics Insights from #AAAI23: Deep learning neural networks, like chatGPT, impress academics. Yet, a noticeable gap exists between improving neural networks and classical reasoning algorithms. Can this gap be bridged to combine their strengths? #AI #neuralnetworks #classicalreasoning
Explainer Data sharing in genomics: The Beacon Protocol This Explainer-series is aimed at describing the “Beacon Protocol”
Scientific publication The Limitations of Current Cystic Fibrosis Screening Recommendations Reproductive carrier testing is an important tool for well-informed family planning especially for inherited recessive disorders like cystic fibrosis. Our recent Prenatal Diagnosis publication in collaboration with Genepath showed that current screening recommendations
case study Case study: Indonesia's PathsBeacon The ClientGSI Lab is the second largest sequencing facility in Indonesia started through the social entrepreneurship initiative to support the Government and society in accelerating the handling of COVID-19. They are registered as
Scientific publication New research finds genomic professionals support patient genomic data ownership in Australia Advances in genomics have huge potential for patient outcomes. But with this momentum comes an ethical tension around the rights of patients to own their data. Our new research explores perceptions of health
Why GWAS matter? As technology improves and associated costs decrease DNA sequencing is becoming more prevalent in health care settings. DNA sequencing technologies are gaining relevance in the clinic because of its decreasing costs and the
Conference Australasian Genomic Technologies Association - AGTA 2022 The AGTA 2022 conference was held on the Sunshine coast and celebrated the 20th anniversary with a variety of topics, including: cancer and medical genomics; plant and animal genomics; computational biology, bioinformatics and statistical genetics.
Trends Terraform Module for EMR Serverless A template to create your own EMR Serverless cluster on AWS, including all necessary IAM roles and some extra features.
Explainer The Many Ways to the Cloud (Part 2): From on prem to EMR Serverless This Explainer-series is aimed at describing the “many ways to the cloud”
case study Case study: Automating neonatal genomic screening pipeline The ClientGenepath is an Australian owned and operated company, using next generation genetic testing for neonatal testing. Genepath developed, NextGen, which is the world’s first accredited, peer reviewed neonatal screening test using
BSEP Bioinformatics Student Exchange Program (BSEP) 2023 The Bioinformatics Student Exchange Program (BSEP) is open for 2023, offering remote as well as options to travel to Australia. BSEP is aimed at overseas students, giving them the opportunity to contribute to
Scientific publication Machine Learning provides early warning for emerging COVID-19 variants Researchers at CSIRO, Australia’s national science agency, have developed a faster and more comprehensive way to identify emerging and dangerous COVID 19 variants, by analysing the DNA of the whole variant, rather
Research Project Increasing the vehicle capacity for gene therapy Gene therapy or living drugs is one of the most exciting areas of biotechnology, and we’d like to tell you about some of the progress we’ve made in expanding the potential
case study Case Study: Boosting product confidence of a world-leading RNA therapeutics start-up CSIRO’s Transformational Bioinformatics group validates the importance of long non-coding RNAs (lncRNAs) as novel cancer therapeutics targets. The ClientAmaroq Therapeutics is a New Zealand-based biotechnology company targeting long non-coding RNAs for next
Explainer Scissors, glue or white-out? Using the CRISPR pencil-case Since the original demonstration that CRISPR-Cas9 can be used to induce targeted changes in a cell's genome, there has been an explosion of new versions and variations of different CRISPR systems. While some
Conference Working Towards Genetic Equity at the 43rd Annual Lorne Genome Conference Last week, the 43rd annual Lorne Genome conference was held in a hybrid format with face-to-face participation at Mantra Lorne as well as through an online portal. Our team presented an oral presentation
Scientific publication Finding viral integrations with isling CSIRO has published a software tool to detect if and where viral DNA has integrated into the genome of its host. This helps assess the consequences of a viral infection and the safety
Cutting Edge Virtual Symposium on Coronaviruses with Disease-X Potential, 28-30 September 2022 contact covsymposium@csiro.au
BSEP Bioinformatics Student Exchange Program (BSEP) 2022 The Bioinformatics Student Exchange Program (BSEP) is back, offering remote as well as options to travel to Australia. BSEP aimed at giving overseas students the opportunity to contribute to world-class research and gain
Dementia Discovering novel drivers of Alzheimer’s disease through genetic interactions Alzheimer’s disease is the most common form of dementia and predominantly affects people over 65 years old. Alzheimer’s disease is driven by multiple genetic and environmental influences, including complex interplay between
Grant Australian Office of National Intelligence funds research project to detect artificially manipulated genomes Dr. Aidan Tay was awarded $350,000 for a two-year fellowship by the Australian Office of National Intelligence to detect artificially manipulated genomes for biosecurity applications. Australia needs protection from biological threats that
